Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Bioarctic's Leqembi Approved In UK For Treatment Of Early Alzheimer's

Aug 22 (Reuters) - BioArctic AB  BIOAb.ST :
    * LEQEMBI (LECANEMAB) APPROVED IN THE UK FOR THE TREATMENT
OF
EARLY ALZHEIMER'S DISEASE

Source text for Eikon:  ID:nWkr79255Y 
Further company coverage:  BIOAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on BioArctic AB

See all news